List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #991 to #1,040.
- ASPEN trial → ASPEN Trial
- ASPIRE → Arixtra Study In Percutaneous Coronary Intervention: A Randomized Evaluation
- ASPM → ASPM (Genetics)
- ASPSCR1 gene → ASPSCR1
- ASRM → American Society of Reproductive Medicine
- ASSENT-1 → Assessment Of The Safety Of A New Thrombolytic: Tnk-Tpa
- ASSENT-2 → Assessment Of The Safety And Efficacy Of A New Thrombolytic: Tnk-Tpa-2
- ASSENT-4 PCI → Assessment Of The Safety And Efficacy Of A New Treatment Strategy For Acute Myocardial Infarction
- ASSENT 3 → The Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen (Assent)-3 Investigators. Efficacy And Safety Of Tenecteplase In Combination With Enoxaparin, Abciximab, Or Unfractionated Heparin: The Assent-3 Randomized Trial In Acute Mi
- ASSENT 3 PLUS → Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen-3
- ASSERT → Aortic Stentless Versus Stented Valve Assessed By Echocardiography Randomized Trial
- ASSET → Anglo-Scandinavian Study Of Early Thrombolysis
- ASSIST → Assessment Of Implementation Strategies
- ASSURE → Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit Of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter Defibrillator Implantations
- ASS (gene) → Argininosuccinate synthetase
- AST → Aspartate transaminase
- ASTAMI → Astami
- ASTEROID → A Study To Evaluate The Effect Of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden
- ASTEROID trial → ASTEROID Trial
- ASTIS → Autologous Stem Cell Transplantation International Scleroderma Trial
- ASTM → ASTM International
- ASTRAL → Angioplasty And Stenting For Renal Artery Lesions
- ASTRID → Atrial Sensing Trial To Prevent Inappropriate Detections
- ASTRONAUT → Acid Suppression Trial: Ranitidine Zantac Versus Omeprazole
- AS transthyretin amyloidosis → Cardiac amyloidosis
- AT → Ataxia telangiectasia
- AT-10 Resin → AT-10 resin
- AT/RT → Atypical teratoid rhabdoid tumor
- AT3 → Antithrombin III
- ATAC → Arimidex (Anastrozole), Tamoxifen And Combination Therapy
- ATBAT → Anticoagulant Therapy With Bivalirudin To Assist In Pci 1St Inning Trial (Pci In Hit/Hitts)
- ATBC → Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study
- ATC → Anaplastic thyroid cancer
- ATC code → Anatomical Therapeutic Chemical Classification System
- ATC codes → Anatomical Therapeutic Chemical Classification System
- ATF1 gene → ATF1
- ATF2 → Activating transcription factor 2
- ATG → Anti-thymocyte globulin
- ATG or AUG → Start codon
- ATHENA → Effect Of Dronedarone On Cardiovascular Outcomes In High-Risk Patients With Atrial Fibrillation Or Atrial Flutter
- ATHEROMA → Atorvastatin Therapy: Effects Of Reduction Of Macrophage Activity
- ATICH → Antifibrinolytic Therapy In Acute Intracerebral Hemorrhage
- ATIC gene → Inosine monophosphate synthase
- ATIII → Antithrombin III
- ATLANTIC → Angina Treatments - - Lasers And Normal Therapies In Comparison
- ATLANTIS → Alteplase Thrombolysis For Acute Noninterventional Therapy In Ischemic Stroke
- ATLAS → Assessment Of Treatment With Lisinopril And Survival
- ATLAS-TIMI 46 → Anti-Xa Therapy To Lower Cardiovascular Events In Addition To Aspirin With Or Without Thienopyridine In Subjects With Acute Coronary Syndromes–Thrombolysis In Myocardial Infarction 46
- ATLAST → Antiplatelet Therapy Alone Versus Lovenox Plus Antiplatelet Therapy In Patients At Increased Risk Of Stent Thrombosis
- ATLAS - SVG → Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts